Page 73 - IJPS-3-1
P. 73

Alves LC and Arruda NM

                                       quintiles. We categorized the first quintile as low income and the fifth quintile as high
                                       income.
                                         We estimated the life expectancy with and without chronic diseases for the Brazilian
                                       elderly population in 1998 and 2008 based on the construction of life tables, which
                                       combined mortality information and prevalence of chronic diseases, as proposed by
                                       the method used by Sullivan (1971). The Sullivan method is the most widely used
                                       to estimate healthy life expectancy or disease-free life expectancy (Imai and Soneji,
                                       2007). The most important figures for calculation of life (and therefore health)
                                       expectancy are the person-years lived in each age group by a future cohort assuming
                                       that the same age-specific mortality rates apply. To calculate these, we need to know
                                       the total time spent in each age group by each member of the cohort. Such data are not
                                       available at the individual level. Instead, we can do the estimation using the population
                                       in each age group and the number of deaths in the age group (Jagger, Hauet and
                                       Brouard, 2001).
                                         The age-specific prevalence with and without chronic disease, and age-specific
                                       mortality rates in the population, are estimates. The expected years with and without
                                       chronic disease are calculated by applying the age- and sex- specific cross-sectional
                                       prevalence rates of these two states to the person-years lived in different age categories
                                       derived from period life tables (Andrade, Corona, Lebrão et al., 2014). So,
                                                                     ∑  1 [  − π  ]  L x            (1)
                                                              DFLE =      n l x  xi  n
                                                                  x
                                         and

                                                                     ∑ [ π  ]  L x              (2)
                                                               LED =    n  xi  n
                                                                  x
                                                                         l x
                                         where DFLE x  is the average number of years that an individual will live without
                                       chronic disease, starting from exact age x whereas life expectancy with chronic disease
                                       (LED x ) is the average number of years that an individual will live with any disease,
                                       starting from exact age x.  n π xi  is the proportion of age group x to x+n with a chronic
                                       disease i, which is the disease prevalence based on the PNAD.  n L x  is a person years
                                       lived in the age interval and l x  is the total number of people who have already survived
                                       to age x. Both are obtained from the life table generated based on estimates provided
                                       by the Mortality Reporting System. 1 –  n π xi  is the proportion of age group x to x+n
                                       without chronic disease i. [1–  n π x ]* n L x  is a person years lived in an age interval without
                                       chronic disease. [ n π x ]* n L x  is a person years lived with chronic disease in age interval x
                                       to x+n. Σ[1 –  n π x  ]* n L x  is a total years lived without chronic disease from age x. It was
                                       obtained as the sum of the all [1–  n π x ]* n L x  from age x up to the final age group (85+).
                                       Σ[ n π x  ]* n L x  is total years lived with at least one chronic disease from age x.
                                         The total life expectancy (TLE) at each age, e x , is found by dividing the total number
                                       of years lived beyond that age by the total number of individuals who have already
                                       survived to age x. Life expectancy with and without chronic disease was estimated
                                       by sex, education and income. All statistical analyses were performed with the aid of
                                       using the software R version 3.2.2 and Microsoft Excel 2010.

                                       3  Results

                                       This section presents the results of chronic disease prevalence and disease-free life
                                       expectancy by age (60 or 80), education (high or low) and income (high or low) for
                                       four conditions: hypertension, diabetes, bronchitis/asthma, and heart disease.
                                         Table 1 shows the prevalence of chronic diseases among elderly Brazilians in
                                       1998 and 2008. This data reveal that the prevalence of diabetes and hypertension has
                                       increased among the elderly and for both sexes during the period. In turn, there has
                                       been a reduction in cardiac and respiratory diseases for both sexes. Hypertension is

            International Journal of Population Studies   2017, Volume 3, Issue 1                             67
   68   69   70   71   72   73   74   75   76   77   78